Shares of Ainos, Inc. AIMD rose sharply in today's pre-market trading after the company announced that it has obtained exclusive licenses for a total of 10 invention patents and patent applications from Taiwan Carbon Nano Technology.
Ainos shares jumped 37.7% to $0.7200 in pre-market trading.
Here are some other stocks moving in pre-market trading.
Gainers
- LogicMark, Inc. LGMK rose 49% to $0.3201 in today's pre-market trading. On Aug. 5, LogicMark announced the closing of $4.5 million public offering priced at-the-market.
- PS International Group Ltd. PSIG gained 27.7% to $1.29 in pre-market trading after jumping 46% on Friday.
- Y-mAbs Therapeutics, Inc. YMAB shares rose 27.3% to $14.28 in pre-market trading.
- FSD Pharma Inc. HUGE gained 24.5% to $0.2490 in pre-market trading. FSD Pharma shares jumped 118% on Friday after Celly Nutrition, which is backed by FSD Pharma, announced the upcoming launch of its ‘unbuzzd’ recovery drink.
- Genius Group Limited GNS gained 18.5% to $0.16. Genius Group shares gained around 8% on Friday after the company announced its board approved the purchase of up to 10 million shares by founder and CEO Roger James Hamilton.
- ProMIS Neurosciences, Inc. PMN gained 15.4% to $1.41 in pre-market trading. The company, last week, posted a narrower-than-expected quarterly loss.
- Adaptimmune Therapeutics plc ADAP jumped 12.8% to $1.12 in pre-market trading.
- Esperion Therapeutics, Inc. ESPR gained 11.4% to $2.25 in pre-market trading.
- AirNet Technology Inc. ANTE shares gained 10.1% to $0.2999 in pre-market trading after declining around 20% on Friday.
Losers
- Meta Materials Inc. MMAT shares declined 27.7% to $0.6810 in pre-market trading. Meta Materials shares dipped around 55% on Friday after the company disclosed in an SEC filing that it ceased operations and filed a voluntary petition for relief under the provisions of Chapter 7 of Title 11 in the US Bankruptcy Court.
- iLearningEngines, Inc. AILE shares dipped 25.8% to $4.29 in pre-market trading. ILearningEngines will report financial results for the second quarter before the opening bell on Tuesday, Aug. 13.
- Tenon Medical, Inc. TNON declined 16.9% to $0.49 in pre-market trading. Tenon Medical will release financial results for the second quarter after the closing bell on Aug. 13.
- Sonoma Pharmaceuticals, Inc. SNOA shares declined 15.4% to $0.21 in pre-market trading. Sonoma Pharmaceuticals shares dipped around 20% on Friday after the company reported worse-than-expected first-quarter financial results.
- Humacyte, Inc. HUMA shares fell 13.4% to $6.85 in pre-market trading after the company announced that the FDA will require additional time to complete its review of the BLA for ATEV in the treatment of vascular trauma.
- Big Tree Cloud Holdings Limited DSY shares fell 11.6% to $1.30 in pre-market trading after jumping 70% on Friday.
- ENDRA Life Sciences Inc. NDRA fell 11.1% to $0.0448 in pre-market trading. ENDRA Life Sciences will report financial results for the three and six months ended June 30 on Wednesday, Aug. 14.
- CareMax, Inc. CMAX fell 7.7% to $4.19 in today's pre-market trading after the company reported worse-than-expected second-quarter results.
- Hawaiian Electric Industries, Inc. HE fell 7.7% to $14.28 pre-market trading after the company reported weak second-quarter earnings.
- Pagaya Technologies Ltd. PGY shares fell 6% to $13.37 in pre-market trading. The company reported second-quarter results on Friday.
ADAPAdaptimmune Therapeutics PLC
$0.5921-1.32%
AILEiLearningEngines Inc
$0.8101-17.1%
ANTEAirNet Technology Inc
$0.4000-0.02%
DSYBig Tree Cloud Holdings Ltd
$3.251.25%
ESPREsperion Therapeutics Inc
$2.180.23%
GNSGenius Group Ltd
$0.58718.72%
HEHawaiian Electric Industries Inc
$9.902.07%
HUMAHumacyte Inc
$4.7537.3%
LGMKLogicMark Inc
$1.52-2.56%
NDRAENDRA Life Sciences Inc
$5.37-%
PGYPagaya Technologies Ltd
$9.053.90%
PMNProMIS Neurosciences Inc
$0.90400.11%
PSIGPS International Group Ltd
$0.482017.5%
SNOASonoma Pharmaceuticals Inc
$2.49-2.35%
TNONTenon Medical Inc
$1.84-4.17%
YMABY-mAbs Therapeutics Inc
$8.28-3.38%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in